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Background: Advancements in ICD technology have resulted in more effective defibrillation, and the need for defibrillation threshold (DFT) 
testing has been questioned. The aim of the current study is to identify contemporary patterns of practice related to DFT testing and to compare 
characteristics of pts who undergo testing versus those who do not.
Methods: 64,227 initial ICD implant procedures performed at 1261 facilities (April 2010 to December 2010) in the NCDR ICD Registry were 
selected to identify patterns of practice related to DFT testing. Pt and hospital characteristics were compared using chi-square test for categorical 
variables and unbalanced T-test for continuous variables.
Results: DFT testing was not performed in 29% of pts. Pts who did not undergo testing were older, more often had heart failure (& higher functional 
class), lower LVEF, atrial arrhythmias, a primary prevention indication, and were undergoing CRT implant. Pts who did not undergo testing were less 
likely implanted in a metropolitan area and more likely implanted at a teaching hospital in New England or Mid Atlantic U.S.
Conclusions: Although clinical trials documenting the efficacy of ICDs all included some form of DFT testing, testing is not performed in many 
(29%) pts. Pts who undergo testing differ from those who don’t with respect to baseline characteristics, ICD type and indication, with regional 
variation by hospital type and location. Prospective randomized data are needed to determine the impact of DFT testing on outcome.
No DFT Testing DFT testing P value
Age, years (mean) 67.4 65.1 <0.001
Heart failure 83% 77% <0.001
NYHA Functional Class III & IV 59% 50% <0.001
Nonischemic dilated CM 47% 35% <0.001
Atrial fibrillation/flutter 44% 27% <0.001
LVEF (%) 27.5% 29.3% <0.001
Indication: Primary prevention 83% 81% <0.001
Device type: CRT 43% 36% <0.001
New England or Mid Atlantic U.S. 21% 15% <0.001
